Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,046 | -649 | -211 | N/A | -512 |
| Depreciation Amortization | 9 | 5 | 3 | N/A | 1 |
| Other Working Capital | -240 | -96 | 157 | N/A | 45 |
| Other Operating Activity | 496 | 328 | -49 | 0 | 33 |
| Operating Cash Flow | $-780 | $-412 | $-100 | $N/A | $-433 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -26 | -24 | N/A | -6 |
| Investing Cash Flow | $-41 | $-26 | $-24 | $N/A | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 175 | 175 | 100 | N/A | N/A |
| Debt Repayment | -175 | -175 | N/A | N/A | N/A |
| Common Stock Issued | 2,489 | 2,280 | N/A | N/A | 508 |
| Financing Cash Flow | $2,489 | $2,280 | $100 | $N/A | $508 |
| Beginning Cash Position | 26 | 26 | 26 | N/A | 201 |
| End Cash Position | 1,693 | 1,868 | 2 | N/A | 270 |
| Net Cash Flow | $1,668 | $1,843 | $-24 | $N/A | $70 |
| Free Cash Flow | |||||
| Operating Cash Flow | -780 | -412 | -100 | N/A | -433 |
| Capital Expenditure | -41 | -26 | -24 | N/A | -6 |
| Free Cash Flow | -821 | -438 | -124 | 0 | -438 |